Following intratumoral injection in the melanoma model, anti-CD137 and interleukin (IL)-2Fc loaded nanoparticles diffused into the tumor parenchyma and tumor-draining lymph nodes, while they were not able to enter the systemic circulation. The gene discussed is TNFRSF9; the disease is melanoma.